Evidence map›Paper›PMID 40979976›Full record

ArticleEuropean heart journal supplements : journal of the European Society of Cardiology2025

May Measurement Month 2022: an analysis of blood pressure screening results from Paraguay.

Abdón Villamayor, Graciela González, Rocío Aparicio, Manuel Castillo, Victoria Chaparro, Thomas Beaney, Gabriele Kerr, Neil R Poulter, José Ortellado

Abstract read
In one paragraph

Article in European heart journal supplements : journal of the European Society of Cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Abdón VillamayorNational Program for Cardiovascular Prevention of the Ministry of Public Health and Social Welfare, Asuncion, CP 1548, Paraguay.
Graciela GonzálezNational Program for Cardiovascular Prevention of the Ministry of Public Health and Social Welfare, Asuncion, CP 1548, Paraguay.
Rocío AparicioNational Program for Cardiovascular Prevention of the Ministry of Public Health and Social Welfare, Asuncion, CP 1548, Paraguay.
Manuel CastilloNational Program for Cardiovascular Prevention of the Ministry of Public Health and Social Welfare, Asuncion, CP 1548, Paraguay.
Victoria ChaparroNational Program for Cardiovascular Prevention of the Ministry of Public Health and Social Welfare, Asuncion, CP 1548, Paraguay.
Thomas BeaneyImperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.ORCID https://orcid.org/0000-0001-9709-7264
Gabriele KerrImperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.
Neil R PoulterImperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.
José OrtelladoNational Program for Cardiovascular Prevention of the Ministry of Public Health and Social Welfare, Asuncion, CP 1548, Paraguay.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The May Measurement Month (MMM) campaign was carried out in Paraguay in 2022 with the aim of raising awareness in the population of increased blood pressure (BP). Adults aged ≥18 years were recruited opportunistically in the country. Three BP readings were taken for each participant, along with completion of a questionnaire on demographics, lifestyle factors, and comorbidities. Hypertension was defined as a systolic BP ≥140 mmHg and/or diastolic BP ≥90 mmHg or being treated with antihypertensive medication. Controlled BP was defined as being on antihypertensive medication with a BP < 140/90 mmHg. Multiple imputation was used to estimate any missing BP readings. In total, 10 475 adults were screened, with a mean age of 48.6 years, and 62.0% were female. Most (57.3%) of the participants were screened in health service settings. Of all participants, 6049 (57.7%) had hypertension, 4367 (72.2%) were aware, 4246 (70.2%) were on antihypertensive medication, of whom 1686 (39.7%) had controlled BP, and of all participants with hypertension 27.9% had controlled BP. Hypertension was more common in male than in female participants (60.1 vs. 56.3%), and male hypertensive participants were less often controlled (21.5 vs. 32.0%). In conclusion, this campaign identified significant numbers of participants with hypertension and a great number on treatment who did not have controlled BP.

Indexed as

Blood pressureControlHypertensionScreeningTreatment

Identifiers

PMID40979976
PMCPMC12449234

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.